Introduction: A High-Stakes Defense
In an effort to reshape its public image and fend off intense federal scrutiny, UnitedHealth Group has released the findings of an independent audit regarding its “HouseCalls” program—a service where clinicians perform in-home health assessments for Medicare Advantage (MA) members. The report, conducted by FTI Consulting, aims to address persistent allegations that the insurance giant uses these visits to “upcode” patient conditions, thereby inflating the reimbursements it receives from the federal government.
The audit, which analyzed a random sample of 200 home visits, concluded that 96.6% of diagnoses identified during these sessions were substantiated by patient medical records. For UnitedHealth, the results serve as a critical piece of evidence in its ongoing defense against accusations of systemic profiteering within the privatized Medicare ecosystem. However, the release has done little to silence critics, who argue that the inherent financial incentives of the Medicare Advantage risk-adjustment model make such programs ripe for abuse, regardless of the audit’s narrow scope.
The Mechanics of the Dispute: Risk Adjustment and “HouseCalls”
To understand the significance of this audit, one must first understand the financial engine of Medicare Advantage. In this system, the federal government pays private insurers a monthly fee per enrollee. Crucially, these payments are “risk-adjusted,” meaning the insurer receives higher payments for sicker patients.
This creates a powerful, systemic incentive for insurers to document as many diagnoses as possible. If a clinician visiting a patient at home identifies a chronic condition that was previously undocumented, the insurer’s “risk score” for that patient rises, and the federal reimbursement increases accordingly.
UnitedHealth’s HouseCalls program is designed to bring care directly to the patient, often reaching seniors who might not regularly visit a primary care physician. The company maintains that this program is a vital tool for preventive care, allowing clinicians to identify health needs that would otherwise remain unaddressed. Conversely, skeptics and federal investigators have long viewed the program as a primary pathway for “risk adjustment gaming,” where companies hunt for diagnoses—often with little clinical relevance—to boost profit margins.
Chronology of Scrutiny and Corporate Response
The release of this audit is not an isolated event but rather the latest chapter in a multi-year saga of legal and public relations challenges for UnitedHealth.
2024: The OIG Bombshell
The pressure on UnitedHealth intensified significantly in 2024, when the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) released a scathing report. The investigation revealed that major Medicare Advantage payers were receiving billions in overpayments, largely driven by diagnoses harvested during in-home health risk assessments. The report specifically noted that of the $7.5 billion in Medicare payments linked to in-home assessments in 2023, UnitedHealth accounted for a staggering $3.7 billion.
The Leadership Pivot
Following a rare quarterly earnings miss—the company’s first since 2008—and amidst mounting civil and criminal investigations into its billing practices, the company saw a shift in leadership. CEO Stephen Hemsley returned to the helm last spring with a clear mandate: restore trust. Hemsley promised an unprecedented level of transparency, pledging to commission independent reviews of the company’s business practices.
December 2025: The First Tranche
In December, the company released the initial findings of its external review. While the review identified areas for internal improvement, it stopped short of confirming the widespread “smoking gun” of systematic fraud that critics had alleged. It was at this time that the company promised a more granular look at the HouseCalls program, which culminated in the current report from FTI Consulting.
Analyzing the Audit: Data and Methodology
The FTI Consulting audit focused on a sample of 200 HouseCalls visits, which accounted for 494 distinct diagnoses. The methodology mirrored the process used by the Centers for Medicare & Medicaid Services (CMS) for its own audits, lending the report a veneer of regulatory legitimacy.
Key Findings:
- The 96.6% Benchmark: FTI found that 477 of the 494 diagnoses (96.6%) were fully supported by the medical record.
- The Error Rate: Only 17 diagnoses were initially flagged as unsupported. This 3.4% error rate was highlighted by UnitedHealth as being three times lower than the error rate reported by the CMS in its most recent comprehensive audit of Medicare Advantage data.
- The Secondary Review: UnitedHealth did not stop at the initial findings. The company argued that when looking beyond the medical record to other data points—such as paid claims history—the majority of the 17 “unsupported” diagnoses were, in fact, clinically valid. Upon further review, FTI agreed that 12 of the 17 diagnoses were backed by other evidence, leaving only 5 diagnoses truly unsupported.
Limitations and Omissions
Despite these figures, independent analysts point to several limitations. The sample size of 200 visits is statistically small relative to the millions of visits conducted by UnitedHealth annually. Furthermore, a spokesperson for the company declined to disclose the financial impact of the 17 initially unsupported diagnoses, leaving it unclear how much federal reimbursement was generated by those specific, potentially erroneous, entries.
Implications for Medicare Advantage and Policy
The debate surrounding the HouseCalls audit has broader implications for the future of Medicare Advantage. As the program continues to consume a larger share of the federal budget, policymakers are increasingly looking for ways to curb costs.
The “Upcoding” Debate
Critics argue that the 3.4% error rate is a “distraction metric.” They contend that the real issue is not necessarily the accuracy of the diagnoses themselves, but the process of searching for them. When insurers perform home visits specifically to find diagnoses that haven’t been captured elsewhere, they are essentially “manufacturing” risk scores. The American Hospital Association and other industry groups have frequently lobbied for stricter regulations on in-home assessments, suggesting that these visits should not be allowed to influence risk adjustment scores at all.
Regulatory Reform
In response to the mounting pressure, UnitedHealth has announced that it has implemented all 23 recommendations provided by its auditors. These include:
- Independent Coding Audits: Creating a firewall between the departments that perform assessments and those that submit billing data.
- Formalized Oversight: Establishing stricter policies for how clinicians are trained and how their findings are documented.
- Transparency Pledges: Hemsley has committed to continuing the release of independent audit findings, positioning transparency as a new corporate cornerstone.
Official Responses and Future Outlook
In a public statement, CEO Stephen Hemsley acknowledged that while the audit results were “meaningful,” the work is far from over. “We are committed to doing better,” Hemsley stated, emphasizing that the company will continue to subject its key practices to outside scrutiny.
However, the medical community remains divided. Supporters of the HouseCalls program point to the tangible benefits for elderly patients who may not have seen a doctor in months, arguing that the assessments provide vital insights into social determinants of health, such as fall risks or medication non-adherence.
Detractors, however, remain skeptical of the “corporate-funded audit” model. They argue that when a company pays a consulting firm to audit its own programs, the findings will inevitably skew toward a defense of the status quo.
As the Department of Justice continues its investigations, the legal and financial stakes remain high. Whether the FTI Consulting report will be enough to quell regulatory intervention remains to be seen. For now, the report serves as a tactical victory for UnitedHealth, providing a data-backed defense that will likely be used in upcoming negotiations with federal regulators.
Ultimately, the controversy highlights the fundamental tension in the American healthcare system: the desire to provide accessible, proactive care for seniors while simultaneously managing the massive financial incentives that threaten to undermine the fiscal integrity of the Medicare program. As UnitedHealth moves forward, the success of its reform pledges will be measured not by internal audits, but by the extent to which it can convince both the public and the federal government that its business practices are as healthy as the patients it serves.
